Zürcher Kantonal Bank logo

Zürcher Kantonal Bank

Europe, Zurich, Switzerland, Zürich

Description

Zürcher Kantonalbank (ZKB) is a prominent cantonal bank based in Zurich, Switzerland, wholly owned by the canton. While it plays a crucial role in the Swiss financial landscape and actively supports the local economy, its operational model does not align with that of a traditional venture capital firm making direct equity investments in startups. ZKB's engagement with the startup ecosystem is primarily through providing banking services, debt financing, and strategic partnerships, rather than taking equity stakes.

The bank offers various financing solutions tailored for small and medium-sized enterprises (SMEs) and startups. For instance, through its "ZKB Start-up Finance" program, it provides loans and guarantees to young companies, helping them secure necessary capital for growth. These financing instruments are typically debt-based, with loan amounts potentially reaching up to CHF 1 million, which translates to approximately USD 1.1 million based on recent exchange rates. This support is designed to facilitate business development and innovation within the region.

Beyond direct financing, ZKB is also a significant patron of innovation through initiatives like the "ZKB Pionierpreis Technopark." This annual award recognizes and supports promising Swiss startups with prize money, fostering entrepreneurial spirit and technological advancement. The main prize for this competition is CHF 100,000, equivalent to roughly USD 110,000, serving as a grant rather than an equity investment.

In summary, Zürcher Kantonalbank functions as a corporate and retail bank that provides comprehensive financial services, including debt financing, to startups and established businesses. Its involvement in the startup ecosystem is robust, but it does not operate as an equity venture capital investor. Therefore, the concept of typical "first cheque sizes" in the context of equity investments is not applicable to ZKB's investment strategy.

Investor Profile

Zürcher Kantonal Bank has backed more than 176 startups, with 13 new investments in the last 12 months alone. The firm has led 22 rounds, about 13% of its total and boasts 13 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A, Series B rounds (top funding stages).
  • Majority of deals are located in Switzerland, Singapore, United Kingdom.
  • Strong thematic focus on Health Care, Biotechnology, Medical Device.
  • Led 1 rounds in the past year.

Stage Focus

  • Seed (35%)
  • Series A (32%)
  • Series B (12%)
  • Series Unknown (12%)
  • Series C (2%)
  • Debt Financing (2%)
  • Convertible Note (2%)
  • Pre Seed (2%)
  • Angel (1%)
  • Undisclosed (1%)

Country Focus

  • Switzerland (95%)
  • Singapore (1%)
  • United Kingdom (1%)
  • Germany (1%)
  • Spain (1%)
  • Japan (1%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical Device
  • Software
  • Medical
  • Information Technology
  • Manufacturing
  • Robotics
  • Saas
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Zürcher Kantonal Bank frequently co-invest with?

SN
Europe, Zurich, Switzerland, Zürich
Co-Investments: 15
SICTIC
Europe, Zurich, Switzerland, Zürich
Co-Investments: 14
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 9
Aargauische Kantonalbank
Europe, Aargau, Switzerland, Aarau
Co-Investments: 6
OCCIDENT
Europe, Bayern, Germany, Munich
Co-Investments: 11
Verve Ventures
Europe, Zug, Switzerland, Zug
Co-Investments: 51
3wVentures
Europe, Ausser-Rhoden, Switzerland, Herisau
Co-Investments: 8
redalpine
Europe, Zurich, Switzerland, Zürich
Co-Investments: 7
Founderful
Europe, Zurich, Switzerland, Zürich
Co-Investments: 9
Business Angels Switzerland (BAS)
Europe, Zurich, Switzerland, Zürich
Co-Investments: 6

Which angels does Zürcher Kantonal Bank often collaborate with?

PL
Europe, Zurich, Switzerland, Zürich
Shared Deals: 3
WM
Europe, Basel-Stadt, Switzerland, Basel
Shared Deals: 1
PK
Europe, Nidwalden, Switzerland, Stans
Shared Deals: 3
AW
North America, District of Columbia, United States, Washington
Shared Deals: 1
RK
Europe, Luxembourg
Shared Deals: 1
PS
Europe, Basel-Landschaft, Switzerland
Shared Deals: 1
RP
Europe, Zurich, Switzerland
Shared Deals: 2
DA
Europe, Basel-Stadt, Switzerland, Basel
Shared Deals: 2
LB
Europe, Zurich, Switzerland, Zürich
Shared Deals: 1
LM
Europe, Zurich, Switzerland, Zürich
Shared Deals: 1

What are some of recent deals done by Zürcher Kantonal Bank?

Seprify

Freiburg, Fribourg, Switzerland

Seprify is a chemical manufacturing company that produces and sells cellulose white pigment solutions.

ChemicalChemical EngineeringManufacturingSustainability
Series AMar 10, 2026
Amount Raised: $15,559,341
Alithea Genomics

Lausanne, Vaud, Switzerland

Alithea Genomics develops molecular biology tools and sequencing-based solutions for large-scale gene expression analysis.

BiopharmaBiotechnologyGenetics
SeedMar 4, 2026
Amount Raised: $3,838,575
Clee Medical

Geneva, Geneve, Switzerland

Clee Medical believes the rapid growth of neurotech is constrained by inefficiencies in surgical tools and techniques.

ManufacturingMedical
SeedFeb 25, 2026
CompPair

Lausanne, Vaud, Switzerland

CompPair is solving damage issues for the composite materials industry by developping smart sustainable textile systems.

3D PrintingEnergy ManagementManufacturingRenewable EnergySustainability
UndisclosedFeb 18, 2026
Haelixa

Kemptthal, Zurich, Switzerland

Haelixa provides IN-product traceability solutions to ensure consumer good supply chain transparency and integrity.

Data Collection and LabelingInformation TechnologyQuality Assurance
SeedFeb 3, 2026
Amount Raised: $2,362,941
TECregen

Basel, Basel-Stadt, Switzerland

TECregen is a biotechnology company that develops thymus-rejuvenating biologics to restore immune function and T-cell responses.

BiotechnologyManufacturingProduct Research
SeedJan 8, 2026
Amount Raised: $12,531,580
Aukera Therapeutics

Basel, Basel-Stadt, Switzerland

Aukera Therapeutics is a biotech company that develops novel therapeutics for patients suffering from mTOR protein related diseases.

BiotechnologyHealth CareTherapeutics
SeedDec 11, 2025
Amount Raised: $5,632,315
arcoris bio

Schlieren, Zurich, Switzerland

arcoris bio provides spatial multiomics solutions focused on transforming biomedical research and diagnostics.

BiotechnologyMedical
SeedNov 6, 2025
Amount Raised: $7,785,082
BTRY

Dubendorf, Zurich, Switzerland

BTRY is a semiconductor manufacturing company that designs and develops fast charging solid-state lithium ion batteries.

BatteryManufacturingRenewable EnergySemiconductor
SeedNov 6, 2025
Amount Raised: $5,700,000
Tethys Robotics

Zürich, Zurich, Switzerland

Tethys Robotics develops underwater drones that enables professionals in carrying underwater search & recovery to inspection & surveillance.

DronesRobotics
Pre SeedOct 30, 2025
Amount Raised: $4,063,214

Find More Investors Like Zürcher Kantonal Bank

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides